Breast cancer cells with high runt-related transcription factor 2 (RUNX2) expression could secrete EVs with high levels of cadherin 11 (CDH11) and integrin α5 (ITGA5), which synergistically promote osteogenic PMN formation. Here, RUNX2 is linked to breast carcinoma.